High performance, point-of-care rapid test for the detection of Influenza A&B Burlington, Massachusetts, Nov. 17, 2020 /PRNewswire/ -- SEKISUI Diagnostics announces it has received CE Marking ...

BURLINGTON, Mass., May 21, 2025 /PRNewswire/ -- SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a new rapid diagnostic testing tool to detect Respiratory ...

The facility, which more than doubled R&D lab space to facilitate process transfer and development, also includes dedicated and separate microbial fermentation development, protein purification, ...

BURLINGTON, Mass., Nov. 14, 2024 /CNW/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK ...

BURLINGTON, Mass., April 2, 2025 /PRNewswire/ -- SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix ® COVID/Flu Test, the second assay on the Metrix ® ...

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen, Inc. Sekisui Diagnostics is now the exclusive ...

Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra ...

LEXINGTON, Massachusetts, Sept. 28, 2016 /PRNewswire/ --Today, Sekisui Diagnostics announces the launch of its new SEKURE® TPLA and RPR assays for Syphilis testing. The SEKURE® TPLA and RPR reagents ...

The new Bioprocess Innovation Centre includes 250m 2 of laboratory space and 134m 2 of office space, more than doubling its R&D laboratory space to facilitate Process Transfer and Development. The new ...